A new study reveals that current medical guidelines for diagnosing primary aldosteronism (PA), a hormonal disorder linked to high blood pressure and increased risk of heart attack, stroke, and kidney disease, may be too restrictive. Researchers found that using broader diagnostic criteria could double the detection rate of PA, identifying many patients who are currently undiagnosed and untreated. The study suggests that PA should be seen as a spectrum rather than a binary diagnosis, and earlier detection with relaxed criteria could prevent serious cardiovascular complications. This finding highlights the need to update screening practices to catch milder cases earlier and improve patient outcomes.
The study on primary aldosteronism screening thresholds offers context for readers interested in health-related market activity. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 19, 2026 18:01 WIB: out of 150 priced US health-sector stocks, 73 rose and 47 fell. Notable movers include Recursion Pharmaceuticals Inc (RXRX) at USD 3.55 with a +2.45% change and a typical hold time of 21 days, Moderna, Inc. (MRNA) at USD 213.00 with a -2.30% change and a typical hold time of 59 days, and Revolution Medicines Inc. (RVMD) at USD 181.96 with a +2.25% change and a typical hold time of 4 days.
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...
Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...
Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...
JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...
